Maetzel Andreas 4
4 · KalVista Pharmaceuticals, Inc. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Maetzel Andreas
Senior Vice President Medical
Transactions
- Award
Stock Option (right to buy)
2021-02-07+10,000→ 10,000 totalExercise: $24.23Exp: 2029-05-15→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2021-02-07+10,000→ 10,000 totalExercise: $10.20Exp: 2030-06-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents performance stock options granted to the Reporting Person on May 15, 2019. As a result of the Reporting Person having met the applicable performance criteria, 1/36 of the total stock options vests monthly over a 3-year period commencing on February 7, 2021 until fully vested, subject to the Reporting Person's continued service through each vesting date.
- [F2]Represents performance stock options granted to the Reporting Person on June 16, 2020. As a result of the Reporting Person having met the applicable performance criteria, 1/36 of the total stock options vests monthly over a 3-year period commencing on February 7, 2021 until fully vested, subject to the Reporting Person's continued service through each vesting date.